Switch to:
More From Other Websites
Medicines Co., Alnylam Jump Ahead In Cholesterol Race Aug 31 2015
Alnylam Presents Positive Data on PCSK9 Synthesis Inhibitor Aug 31 2015
Mid-Afternoon Market Update: NASDAQ Down 1.3%; Medicines Company Shares Gain Following Announcement... Aug 31 2015
3 High-Volume Stocks to Trade Now (or Not) Aug 31 2015
Mid-Day Market Update: Crude Oil Surges 5.5%; ConforMIS Shares Tumble Aug 31 2015
Medicines (MDCO) Stock Skyrockets Following Promising Cholesterol Drug Results Aug 31 2015
The Medicines Company (MDCO) and Alnylam Pharmaceuticals Inc. (ALNY)’s Positive Phase I Results... Aug 31 2015
Mid-Morning Market Update: Markets Open Lower; Carlyle Group To Acquire Blyth For $6/Share Aug 31 2015
Medicines Shares Surge on Cholesterol-Drug Data Aug 31 2015
The Medicines Company and Alnylam Rise on Positive Phase 1 Results Aug 31 2015
The Medicines Company Appoints Dr. Fred Eshelman as Non-Executive Chairman of the Board Aug 31 2015
Medicines shares surge on upbeat cholesterol drug study Aug 31 2015
Medicines shares surge on upbeat cholesterol drug study Aug 31 2015
MEDICINES CO /DE Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale... Aug 31 2015
The Medicines Company Appoints Dr. Fred Eshelman as Non-Executive Chairman of the Board Aug 31 2015
7:29 am The Medicines Co up ~20% premarket following positive ongoing Phase 1 clinical trial with... Aug 31 2015
Cholesterol-fighting 'game changer': Alnylam CEO Aug 31 2015
​Trial suggests Alnylam's cholesterol-lowering drug may last longer than Amgen's Aug 30 2015
ALN-PCSsc Achieves Quarterly and Potentially Bi-Annual Subcutaneous Dose Regimen Profile for... Aug 30 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK